Revelation Biosciences, Inc. (REVBW) stock
REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $16.05MP/E –Yield –
Revelation Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Revelation Biosciences's market cap was $12.84M on Oct 19, 2026, against $7.67M a year earlier. Over the last 5 years it ranged from $1.37M to $102.72B, with a median of $3.62B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $12.84M | +11.9% |
| 2025 | Dec 31, 2025 | $11.47M | -99.6% |
| 2024 | Dec 31, 2024 | $2.66B | -84.3% |
| 2023 | Dec 29, 2023 | $16.95B | -31.5% |
| 2022 | Dec 30, 2022 | $24.76B | -75.9% |
| 2021 | Dec 31, 2021 | $102.72B | -14.4% |
| 2020 | Dec 31, 2020 | $119.95B | – |